DOSSIER · 13F Holders · Q3 2026
CYTOMED THERAPEUTICS LIMITED
5 institutions still hold CYTOMED THERAPEUTICS LIMITED as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP Y1R80M106·5 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
5 institutions reported CYTOMED THERAPEUTICS LIMITED in Q3 2026. UBS Group AG leads at 41.9% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.